BioSpace News Archive

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) this week shared new data revealing the burden of chronic hypoparathyroidism on patients and caregivers, as well as potential long-term risks of renal and cardiovascular complications that patients treated with conventional therapy may experience

MEDL Mobile was awarded Gold in the AAFOC’s 2019 Addy Awards Mobile App category after a mobile app they developed on behalf of Body Surface Translations was chosen by a panel of industry experts who led the judging process.

Graduating osteopathic physicians are increasingly planning to practice in primary care, a trend researchers say shows that loan forgiveness incentives are influencing new doctors’ choice of specialty, according to a new study in The Journal of the American Osteopathic Association.

With a laser focus on new horizons in neuromuscular research and care, the Muscular Dystrophy Association (MDA) is combining its Clinical and Scientific Conferences for the first time, establishing a robust, state-of-the-art gathering for both clinicians and investigators from across the nation.

EarlySense, the market leader in contact-free continuous monitoring solutions across the care continuum, announced today the results of a randomized controlled clinical study conducted at the University of Chicago, which found significant benefit to low-risk patients who are not woken during the night for vital sign assessments.

The not-for-profit Sutter Health network announced today that it is teaming up with Suki to pilot an artificial intelligence-powered, voice-enabled digital assistant with doctors in Northern California.

On March 9, more than 11,000 people participated in Ride for a Reason, a national indoor cycle event benefiting St. Jude Children’s Research Hospital® and the Life Time Foundation, raising more than $1.81 million to date.

Elite Hearing Network, the largest network of independent hearing care providers in the United States, has named Gray Fleming to the role of Senior Vice President.

New Ventures BC and BioTalent Canada today announced a new partnership to assist BC biotech companies to access funding to hire post-secondary students for business and tech roles to help drive their objectives forward.

CalciMedica, a clinical-stage biopharmaceutical company developing CM4620, a novel small molecule compound for acute pancreatitis, announced that A. Rachel Leheny, Ph.D., has joined its Board of Directors.